Star Source Multi Trade Stock Screener | Share Price & Fundamental Analysis
STARSOURCE
Pharmaceuticals
Screen Star Source Multi Trade share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹134.55
▼
-7.05 (-4.98%)
Market Cap
₹17.64 Cr.
P/B Ratio
10.98
EPS (TTM)
₹-9.66
Dividend Yield
-
Debt to Equity
-
52W High
₹141.60
52W Low
₹100.15
Operating Margin
-
Profit Margin
-
EBITDA
-
Net Income
-
Total Assets
₹4.00
Total Equity
₹4.00
Star Source Multi Trade Share Price History - Stock Screener Chart
Screen STARSOURCE historical share price movements with interactive charts. Analyze price trends and patterns.
Star Source Multi Trade Company Profile - Fundamental Screener
Screen Star Source Multi Trade company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for STARSOURCE shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE320M01019
Star Source Multi Trade Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen STARSOURCE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2016 |
|---|---|
| Assets | |
| Total Assets | 4 |
| Current Assets | 2 |
| Fixed Assets | 0 |
| Liabilities | |
| Total Liabilities | 4 |
| Current Liabilities | 0 |
| Non-Current Liabilities | 0 |
| Shareholders' Equity | |
| Total Equity | 4 |
| Share Capital | 2 |
| Reserves & Surplus | 2 |
Screen STARSOURCE income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2016-March |
|---|---|---|
| Revenue | 0 | -1 |
| Expenses | 0 | 0 |
| EBITDA | 0 | -1 |
| Operating Profit % | 0.00% | 0.00% |
| Depreciation | 0 | 0 |
| Interest | 0 | 0 |
| Profit Before Tax | 0 | -1 |
| Tax | 0 | 0 |
| Net Profit | 0 | -1 |
| EPS | 0.00 | -9.66 |
Star Source Multi Trade Cash Flow Screener - Liquidity Fundamentals
Screen STARSOURCE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2016-March |
|---|---|
| Operating Activities | -2 |
| Investing Activities | 2 |
| Financing Activities | 0 |
| Net Cash Flow | 0 |
Screen STARSOURCE shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 27.89% | 27.89% | 27.89% | 27.89% | 27.89% | 27.89% | 27.89% | 27.89% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.37% | 0.37% | 0.37% | 0.37% | 0.37% | 0.37% | 0.37% | 0.37% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 65.29% | 65.77% | 65.66% | 65.61% | 65.63% | 65.60% | 65.50% | 65.40% |
| Other Holding | 6.46% | 5.98% | 6.09% | 6.14% | 6.12% | 6.15% | 6.25% | 6.35% |
| Shareholder Count | 6,510 | 6,422 | 6,409 | 6,262 | 6,254 | 6,382 | 6,576 | 6,289 |
Star Source Multi Trade Dividend Screener - Share Yield Analysis
Screen STARSOURCE dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Star Source Multi Trade Index Membership - Market Screener Classification
Screen STARSOURCE by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Star Source Multi Trade Market Events Screener - Corporate Actions
Screen STARSOURCE market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Change Of Name | NA | 0.00% | ||
| Annual General Meeting | NA | -5.56% | ||
| Annual General Meeting | NA | -13.88% | ||
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 7.76% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | 11.63% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 18.64% |
| 2025-01-27 | 2025-01-27 | Quarterly Result Announcement | NA | -12.17% |
| 2024-10-28 | 2024-10-28 | Quarterly Result Announcement | NA | -7.07% |
Star Source Multi Trade Competitors Screener - Peer Comparison
Screen STARSOURCE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 423,027 | 39.93 | 54,729 | 9.71% | 10,980 | 42.57 |
| Divis Laboratories | 173,099 | 69.20 | 9,712 | 18.67% | 2,191 | 54.31 |
| Torrent Pharmaceuticals | 128,880 | 60.10 | 11,539 | 6.99% | 1,911 | 59.28 |
| Cipla | 122,100 | 22.55 | 28,410 | 7.12% | 5,291 | 51.13 |
| Dr Reddys Laboratories | 106,847 | 18.60 | 33,741 | 16.73% | 5,725 | 57.95 |
| Lupin | 96,928 | 22.34 | 22,910 | 13.74% | 3,306 | 65.19 |
| Zydus Life Science | 92,724 | 18.40 | 23,511 | 18.55% | 4,615 | 40.83 |
| Mankind Pharma | 89,924 | 50.59 | 12,744 | 20.90% | 2,007 | 42.47 |
| Aurobindo Pharma | 71,328 | 20.79 | 32,346 | 9.43% | 3,484 | 60.10 |
| Alkem Laboratories | 67,196 | 27.59 | 13,458 | 3.70% | 2,216 | 43.27 |
Star Source Multi Trade Company Announcements - News Screener
Screen STARSOURCE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-31 | Intimation Of Receipt Of No-Objection Letter For Reclassification Of Promoter(S) /Promoter Group Under Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-12-03 | Intimation Of Receipt Of Request For Reclassification From Promoter Group Shareholder To Public Shareholder Under Regulation 31A Of The SEBI (LODR) Regulations 2015 | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-13 | Results For The Quarter And Half Year Ended September 30 2025 | View |
| 2025-11-13 | Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 | View |
| 2025-11-10 | Board Meeting Intimation for For Considering And Approving Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-10-16 | Updates on revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-10-14 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-10-10 | Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulation 2015 | View |
| 2025-10-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-01 | Announcement under Regulation 30 (LODR)-Change of Company Name | View |
| 2025-09-25 | Closure of Trading Window | View |
| 2025-09-25 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-09-25 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-24 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-23 | Intimation Of Submission Of Application For Reclassification Of Person Forming Part Of Promoter/Promoter Group From Promoter Group Category Shareholder To Public Category Shareholder Under Regulation 31A Of SEBI (LODR) Regulation2015 | View |
| 2025-09-12 | Appointment of Company Secretary and Compliance Officer | View |
| 2025-08-29 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-28 | Notice Of 83Rd AGM Scheduled On 24Th September 2025 | View |
| 2025-08-28 | Reg. 34 (1) Annual Report. | View |